Molecular Formula | C26H30ClFN2O2 |
Molar Mass | 456.98 |
Boling Point | 611°C at 760 mmHg |
Flash Point | 323.3°C |
Solubility | DMSO: ~10mg/mL, soluble |
Vapor Presure | 8.77E-16mmHg at 25°C |
Appearance | solid |
Color | white |
Storage Condition | 2-8°C |
In vivo study | Levocabastine (0.25 mg/kg; i.p.; twice a day for five successive days; guinea-pigs) inhibits the virus-induced airway hyperresponsiveness, suppresses the influx of broncho-alveolar cells and increase in albumin content, and corrects the reduced chemiluminescence production by broncho-alveolar cells in response to zymosan. In mice that receivedβ-LT, Levocabastine (0.05 mg/kg; i.p.) blocks the anxiolytic effect of β-LT and the number of head-dips decreased. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
HS Code | 2933399090 |